Effect of Hepatitis G Virus Infection on Progression of HIV Infection in Patients with Hemophilia

  1. Anthony E.T. Yeo, MD, MPH, PhD;
  2. Akihiro Matsumoto, MD, PhD;
  3. Michie Hisada, MD, ScD;
  4. James W. Shih, PhD;
  5. Harvey J. Alter, MD;
  6. James J. Goedert, MD; and
  7. for the Multicenter Hemophilia Cohort Study*
  1. From the National Institutes of Health, Bethesda, Maryland.
    1. Figure. Error bars represent 95% CIs. Twelve-year AIDS-free survival was significantly better in patients who were positive for the hepatitis G virus ( ) (68% [CI, 55% to 81%]) than in those who were HGV-negative (40% [CI, 28% to 52%]) ( = 0.03).
      View larger version:
      Figure. Error bars represent 95% CIs. Twelve-year AIDS-free survival was significantly better in patients who were positive for the hepatitis G virus ( ) (68% [CI, 55% to 81%]) than in those who were HGV-negative (40% [CI, 28% to 52%]) ( = 0.03). Product-limit AIDS-free survival (Kaplan–Meier method) measured from estimated dates of HIV seroconversion for 131 patients in the Multicenter Hemophilia Cohort Study.HGVP

    Summary for Patients

    « Previous | Next Article »Table of Contents